Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli.
about
Distribution, levels and phosphorylation of Raf-1 in Alzheimer's disease.Interaction of Grb2 SH3 domain with UVRAG in an Alzheimer's disease-like scenario.Cell cycle events in neurons. Proliferation or death?The role of cell cycle-mediated events in Alzheimer's disease.Cellular levels of Grb2 and cytoskeleton stability are correlated in a neurodegenerative scenario.Mutation in E1, the ubiquitin activating enzyme, reduces Drosophila lifespan and results in motor impairment.Dissociation of ERK signalling inhibition from the anti-amyloidogenic action of synthetic ceramide analoguesEvidence of DNA damage in Alzheimer disease: phosphorylation of histone H2AX in astrocytesPremature centromere division of the X chromosome in neurons in Alzheimer's disease.Cell cycle re-entry mediated neurodegeneration and its treatment role in the pathogenesis of Alzheimer's disease.Evidence for the progression through S-phase in the ectopic cell cycle re-entry of neurons in Alzheimer disease.Cyclin-dependent kinases as a therapeutic target for stroke.All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's diseaseLink between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletionActivation of Ras-ERK Signaling and GSK-3 by Amyloid Precursor Protein and Amyloid Beta Facilitates Neurodegeneration in Alzheimer's Disease.Increased p27, an essential component of cell cycle control, in Alzheimer's disease.ERK activation and expression of neuronal cell cycle markers in the hippocampus after entorhinal cortex lesion.Thinking Outside the Box in Alzheimer Disease Treatment
P2860
Q27864126-0387C139-7206-4796-98F5-4175D662DB93Q30009416-45098B3B-CB19-42C6-9BAF-43E55D248023Q33703735-13E5D2AE-8576-4E91-87D7-4739942CDAF1Q33723773-4F92EBB2-4ECE-4E15-A14B-233793E36740Q33746251-212080AC-1D26-4128-9C86-2164B14F28B5Q34574992-1F34BEE5-82E2-4200-8F93-7A7DC2980C7FQ35676462-7440ECC3-7615-4037-B9D5-68BED386E3D6Q36979395-6A9A15F1-B8C7-49F0-BCEA-A6AD03562CE1Q37353631-C5887140-E4B3-45B3-9F76-553838CFA168Q37359655-137AC48C-0F7C-4FF6-BE55-9989F4D4CB5CQ37439838-A225BA6F-E6C3-4DF2-83E8-8501764DA244Q37445826-FD8C514D-61FC-49B6-94EA-9222F205F4F1Q37630540-FDD86297-7D73-4BDF-9924-01A833AD23B7Q38108308-BA56998C-5B7B-4F46-B6BD-912EF2420211Q38857243-7044ED85-980F-417C-AABC-EDBFD6B3695EQ44526525-F39C5E91-F3B5-4657-9B9A-4CC3D6E03098Q48435650-78B311D9-3E71-497C-96B4-2569C3BB0F53Q57341342-3F179505-A4F6-4915-BA06-B4DD42F827D3
P2860
Signal transduction abnormalities in Alzheimer's disease: evidence of a pathogenic stimuli.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@en
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@nl
type
label
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@en
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@nl
prefLabel
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@en
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@nl
P2093
P1433
P1476
Signal transduction abnormalit ...... dence of a pathogenic stimuli.
@en
P2093
P304
P356
10.1016/S0006-8993(98)01135-4
P407
P577
1999-01-01T00:00:00Z